ACH
Accendra Health, Inc. NYSE Listed Mar 17, 1980$3.20
Pre-mkt
$3.11
-2.81%
Mkt Cap $246.1M
52w Low $1.91
17.2% of range
52w High $9.42
50d MA $3.15
200d MA $3.21
P/E (TTM)
-0.2x
EV/EBITDA
5.3x
P/B
—
Debt/Equity
-4.8x
ROE
238.8%
P/FCF
-0.8x
RSI (14)
61.40
ATR (14)
$0.24
Beta
1.26
50d MA
$3.15
200d MA
$3.21
Avg Volume
928.9K
Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company worldwide. The company operates in two segments, Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, including supplier management, analytics, inventory management, and clinical supply management; and various programs to provide outsourced logistics and marketing solutions to its suppliers. The Patient Direct segment provides products and services for in-home care and delivery across diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment. This segment also supplies a range of other home medical equipment; and patient care products, including ostomy, wound care, urology, and incontinence and other products and services. The company serves multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors. Accendra Health, Inc. was formerly known as Owens & Minor, Inc. and changed its name Accendra Health, Inc. in December 2025. The company was founded in 1882 and is based in Glen Allen, Virginia.
10900 Nuckols Road · Glen Allen, VA 23060 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 11, 2026 | TNS | -0.06 | -0.04 | +33.3% | 3.89 | -1.5% | -17.7% | -1.6% | -3.5% | -4.3% | -5.8% | — |
| Feb 19, 2026 | TNS | 0.22 | 0.21 | -4.5% | 2.48 | -12.1% | +5.2% | -0.4% | +2.3% | -2.3% | -6.9% | — |
| Oct 30, 2025 | TNS | 0.23 | 0.25 | +8.7% | 4.96 | +0.4% | -20.0% | -13.1% | +1.2% | -4.0% | -6.9% | — |
| Aug 11, 2025 | TNS | 0.27 | 0.26 | -3.7% | 4.63 | +0.4% | +18.1% | -2.6% | +1.3% | +5.2% | -4.0% | — |
| May 8, 2025 | TNS | 0.20 | 0.23 | +15.0% | 6.99 | +0.9% | +0.3% | +2.0% | +1.1% | -3.2% | +1.3% | — |
| Feb 28, 2025 | TNS | 0.53 | 0.55 | +3.8% | 9.58 | -1.9% | -2.7% | +4.2% | +0.3% | +2.4% | +0.3% | — |
| Nov 4, 2024 | TNS | 0.40 | 0.42 | +5.0% | 12.00 | -1.5% | -1.7% | +15.3% | -6.2% | +1.1% | +3.6% | — |
| Aug 2, 2024 | TNS | 0.33 | 0.36 | +9.1% | 16.20 | -5.7% | -8.2% | +3.6% | -3.8% | +3.3% | -0.9% | — |
| May 3, 2024 | TNS | 0.17 | 0.19 | +11.8% | 18.21 | +0.2% | +5.5% | -1.6% | -4.2% | +1.4% | +1.4% | — |
| Feb 20, 2024 | TNS | 0.68 | 0.69 | +1.5% | 21.54 | +0.2% | +1.2% | +6.5% | +2.9% | -0.8% | +4.6% | — |
| Nov 3, 2023 | TNS | 0.36 | 0.44 | +22.2% | 19.71 | -2.6% | -1.7% | +1.9% | -6.4% | -4.6% | -2.3% | — |
| Aug 4, 2023 | TNS | 0.16 | 0.18 | +12.5% | 19.02 | -2.4% | +1.2% | -2.0% | +8.0% | -0.8% | -0.1% | — |
| May 5, 2023 | AMC | -0.09 | 0.05 | +155.6% | 18.63 | +3.2% | -4.6% | -1.1% | +4.5% | +1.2% | +0.6% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 20 | Leerink Partners | Maintains | Market Perform → Market Perform | — | $2.48 | $2.18 | -12.1% | +5.2% | -0.4% | +2.3% | -2.3% | -6.9% |
| Jan 9 | Citigroup | Maintains | Buy → Buy | — | $2.36 | $2.36 | +0.0% | +4.2% | +8.9% | -6.3% | +2.8% | -1.9% |
| Nov 3 | UBS | Downgrade | Buy → Neutral | — | $3.97 | $3.83 | -3.5% | -13.1% | +1.2% | -4.0% | -6.9% | +1.9% |
| Aug 27 | JP Morgan | Maintains | Underweight → Underweight | — | $5.01 | $5.00 | -0.2% | -2.4% | +1.4% | -1.2% | +8.8% | +2.8% |
| Aug 13 | UBS | Maintains | Buy → Buy | — | $5.47 | $5.57 | +1.8% | -2.6% | +1.3% | +5.2% | -4.0% | -1.7% |
| Aug 12 | BofA Securities | Maintains | Underperform → Underperform | — | $4.63 | $4.65 | +0.4% | +18.1% | -2.6% | +1.3% | +5.2% | -4.0% |
| Aug 12 | Citigroup | Maintains | Buy → Buy | — | $4.63 | $4.65 | +0.4% | +18.1% | -2.6% | +1.3% | +5.2% | -4.0% |
| Aug 12 | Baird | Maintains | Outperform → Outperform | — | $4.63 | $4.65 | +0.4% | +18.1% | -2.6% | +1.3% | +5.2% | -4.0% |
| Aug 7 | Credit Suisse | Maintains | Neutral → Neutral | — | $19.02 | $18.57 | -2.4% | +1.2% | -2.0% | +8.0% | -0.8% | -0.1% |
| May 7 | Citigroup | Maintains | Neutral → Neutral | — | — | — | — | — | — | — | — | — |
| May 7 | UBS | Maintains | Buy → Buy | — | — | — | — | — | — | — | — | — |
| May 7 | Credit Suisse | Maintains | Neutral → Neutral | — | — | — | — | — | — | — | — | — |
| May 7 | Baird | Maintains | Neutral → Neutral | — | — | — | — | — | — | — | — | — |
| Mar 7 | Citigroup | Maintains | Neutral → Neutral | — | $15.51 | $15.44 | -0.5% | -6.5% | +0.8% | -4.4% | -4.6% | +1.0% |
| Mar 6 | Credit Suisse | Maintains | Neutral → Neutral | — | $16.90 | $16.90 | +0.0% | -8.2% | -6.5% | +0.8% | -4.4% | -4.6% |
| Feb 28 | Baird | Maintains | Neutral → Neutral | — | $19.61 | $16.60 | -15.3% | -21.8% | +0.7% | +6.2% | +3.0% | -8.2% |
| Nov 2 | Citigroup | Maintains | Neutral → Neutral | — | $17.55 | $17.68 | +0.7% | +4.9% | -1.0% | +5.0% | +0.1% | -1.0% |
| Oct 13 | Credit Suisse | Maintains | Neutral → Neutral | — | $15.10 | $14.36 | -4.9% | +1.8% | +0.1% | +7.3% | +0.9% | -2.8% |
| Oct 12 | Citigroup | Downgrade | Buy → Neutral | — | $23.22 | $18.48 | -20.4% | -35.0% | +1.8% | +0.1% | +7.3% | +0.9% |
| Oct 11 | Baird | Downgrade | Outperform → Neutral | — | $23.04 | $23.04 | +0.0% | +0.8% | -35.0% | +1.8% | +0.1% | +7.3% |
| Aug 3 | Baird | Maintains | Outperform → Outperform | — | $36.64 | $33.00 | -9.9% | -11.5% | +0.8% | +0.1% | +4.5% | -2.7% |
| Aug 3 | Credit Suisse | Maintains | Neutral → Neutral | — | $36.64 | $33.00 | -9.9% | -11.5% | +0.8% | +0.1% | +4.5% | -2.7% |
| Feb 27 | Credit Suisse | Maintains | Neutral → Neutral | — | — | — | — | — | — | — | — | — |
| Aug 3 | Credit Suisse | Maintains | Neutral → Neutral | — | $46.90 | $42.45 | -9.5% | -8.8% | -8.8% | -0.5% | +0.5% | -0.7% |
| May 26 | Credit Suisse | Maintains | Neutral → Neutral | — | $32.40 | $33.89 | +4.6% | +36.2% | +2.4% | -1.0% | -4.6% | -0.7% |
| May 10 | Credit Suisse | Maintains | Neutral → Neutral | — | $34.31 | $34.10 | -0.6% | -2.6% | +0.9% | -4.3% | -2.6% | +1.4% |
| Nov 4 | UBS | Maintains | Neutral → Neutral | — | $25.45 | $25.83 | +1.5% | -6.3% | +6.3% | -3.4% | -8.2% | -1.5% |
| Sep 24 | Barclays | Upgrade | Underweight → Equal Weight | — | $13.79 | $19.19 | +39.2% | +47.3% | +0.2% | +6.5% | +8.4% | +6.8% |
| Sep 24 | Credit Suisse | Maintains | Neutral → Neutral | — | $13.79 | $19.19 | +39.2% | +47.3% | +0.2% | +6.5% | +8.4% | +6.8% |
| Aug 6 | Credit Suisse | Maintains | Neutral → Neutral | — | $14.25 | $13.97 | -2.0% | -7.3% | -3.5% | +8.0% | +7.6% | +8.9% |
| Jul 21 | Barclays | Maintains | Underweight → Underweight | — | $7.94 | $10.24 | +29.0% | +81.4% | -10.6% | +15.9% | +0.6% | +3.7% |
| Jun 9 | CFRA | Maintains | Buy → Buy | — | $9.12 | $9.03 | -1.0% | -6.7% | -7.6% | -7.1% | -0.1% | +2.6% |
| May 6 | CFRA | Maintains | Buy → Buy | — | $7.47 | $7.24 | -3.1% | -12.6% | +7.2% | -3.6% | +7.4% | -7.4% |
| May 4 | Baird | Downgrade | Outperform → Neutral | — | $7.36 | $7.40 | +0.5% | +9.1% | -7.0% | -12.6% | +7.2% | -3.6% |
| Mar 29 | CFRA | Upgrade | Hold → Buy | — | — | — | — | — | — | — | — | — |
| Jan 20 | Baird | Upgrade | Neutral → Outperform | — | — | — | — | — | — | — | — | — |
| Jan 17 | UBS | Maintains | Neutral → Neutral | — | $7.63 | $7.55 | -1.0% | -3.9% | -0.8% | +6.2% | -3.9% | +1.2% |
| Jan 3 | BofA Securities | Maintains | Neutral → Neutral | — | $6.51 | $6.50 | -0.2% | -0.6% | +0.5% | +0.2% | -2.8% | +11.2% |
| Jan 2 | BofA Securities | Maintains | Neutral → Neutral | — | $6.33 | $6.25 | -1.3% | +2.8% | -0.6% | +0.5% | +0.2% | -2.8% |
| Oct 31 | Barclays | Maintains | Underweight → Underweight | — | $14.20 | $10.74 | -24.4% | -44.4% | +12.2% | +6.2% | -0.2% | -1.2% |
| Mar 8 | Barclays | Maintains | Underweight → Underweight | — | $17.11 | $17.08 | -0.2% | -1.8% | +1.3% | +1.9% | -1.1% | -2.7% |
| Feb 14 | JP Morgan | Maintains | Underweight → Underweight | — | $14.94 | $15.25 | +2.1% | +2.6% | +1.8% | +3.1% | -4.2% | +3.2% |
| Dec 18 | JP Morgan | Downgrade | Neutral → Underweight | — | $19.05 | $19.08 | +0.2% | -1.6% | +3.5% | +0.3% | -0.4% | -2.3% |
| Nov 19 | Credit Suisse | Maintains | Underperform → Underperform | — | — | — | — | — | — | — | — | — |
| Nov 1 | Leerink Swann | Maintains | Market Perform → Market Perform | — | $24.57 | $24.43 | -0.6% | -14.7% | -10.9% | +4.7% | -1.0% | -1.4% |
| Aug 31 | Baird | Upgrade | Underperform → Neutral | — | $27.74 | $27.89 | +0.5% | +0.7% | +1.4% | -0.8% | +1.4% | -0.5% |
| Nov 7 | BofA Securities | Downgrade | Neutral → Underperform | — | $32.63 | $32.44 | -0.6% | -2.1% | +0.3% | -0.2% | +1.1% | +1.3% |
| Nov 6 | BofA Securities | Downgrade | Neutral → Underperform | — | — | — | — | — | — | — | — | — |
| Oct 6 | UBS | Maintains | Sell → Sell | — | $33.68 | $33.23 | -1.3% | +0.4% | +0.1% | +1.0% | -2.2% | +0.2% |
| Apr 20 | Baird | Downgrade | Neutral → Underperform | — | $41.20 | $38.34 | -6.9% | -9.0% | -2.7% | +1.3% | +0.3% | +0.4% |
No insider trades available.
8-K
Accendra Health, Inc. -- 8-K Filing
May 15
8-K · 7.01
! Medium
Accendra Health, Inc. -- 8-K 7.01: Regulation FD Disclosure
May 11
8-K · 2.02
!! High
Accendra Health, Inc. -- 8-K 2.02: Earnings Results
May 11
8-K · 7.01
! Medium
Accendra Health, Inc. -- 8-K 7.01: Regulation FD Disclosure
Accendra Health disclosed its earnings presentation on its investor relations website on February 19, 2026, providing transparency to shareholders about financial performance and outlook.
Feb 19
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Bank Of America Corp /de/ | 3,407,075 | $8M | Added | Mar 2026 |
| 2 | D.e. Shaw & Co | 3,311,601 | $8M | Reduced | Mar 2026 |
| 3 | Vanguard Capital Management Llc | 3,282,174 | $7M | New | Mar 2026 |
| 4 | Vanguard Portfolio Management Llc | 2,651,152 | $6M | New | Mar 2026 |
| 5 | Morgan Stanley | 1,525,514 | $4M | Reduced | Dec 2025 |
| 6 | Marshall Wace, Llp | 1,761,004 | $4M | Added | Mar 2026 |
| 7 | Connor, Clark & Lunn Investment Management Ltd. | 1,281,357 | $4M | Added | Dec 2025 |
| 8 | Dana Investment Advisors, Inc. | 1,485,097 | $3M | — | Mar 2026 |
| 9 | Jane Street Group, Llc | 1,070,909 | $3M | Reduced | Dec 2025 |
| 10 | Two Sigma Investments, Lp | 1,201,269 | $3M | Added | Mar 2026 |
| 11 | Acadian Asset Management Llc | 907,096 | $2M | Added | Mar 2026 |
| 12 | Aqr Capital Management Llc | 732,221 | $2M | Added | Mar 2026 |
| 13 | Wolverine Asset Management Llc | 695,415 | $2M | Added | Mar 2026 |
| 14 | Northern Trust Corp | 600,961 | $1M | Added | Mar 2026 |
| 15 | Millennium Management | 474,788 | $1M | Reduced | Mar 2026 |
| 16 | Citigroup Inc | 337,932 | $946K | Added | Dec 2025 |
| 17 | Susquehanna International Group, Llp | 360,210 | $821K | Added | Mar 2026 |
| 18 | Renaissance Technologies Llc | 317,913 | $725K | Reduced | Mar 2026 |
| 19 | Ubs Group Ag | 308,734 | $704K | Reduced | Mar 2026 |
| 20 | Bank Of New York Mellon Corp | 259,792 | $592K | Reduced | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$246.1M
Enterprise Value
$1.83B
P/E (TTM)
-0.23x
Forward P/E
4.55x
PEG Ratio
-0.00x
P/B
—
P/S
0.09x
P/FCF
-0.84x
EV/EBITDA
5.33x
Shares Out
76.9M
Financials (TTM)
Revenue
$2.72B
Net Income
-$1.08B
EBITDA
$344.1M
Free Cash Flow
-$292.7M
Op Cash Flow
-$101.8M
EPS Basic
$-14.31
EPS Diluted
$-14.05
EPS Forward
$0.70
Gross Margin
41.3%
Op Margin
3.5%
Net Margin
-39.8%
Balance Sheet
Total Assets
$2.45B
Total Liab.
$2.91B
Total Equity
-$461.0M
Cash
$282.0M
LT Debt
$1.87B
Book Value/Sh
$-5.99
Debt/Equity
-4.85x
Current Ratio
0.58
Quick Ratio
0.50
Returns & Growth
ROE
238.8%
ROA
-44.9%
ROIC
8.3%
Rev Growth YoY
-74.2%
EPS Growth YoY
-202.5%
Price Returns
2W
-6.6%
1M
-23.5%
3M
+17.4%
6M
+4.4%
12M
-57.0%
Technicals
52W High
$9.42
52W Low
$1.91
50d MA
$3.15
200d MA
$3.21
RSI (14)
61.40
ATR (14)
$0.24
Beta
1.26
Avg Volume
929K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
1
Ex-Div Date
Jun 30, 2022
Analyst Price Targets
Consensus
$4.00
High
$5.00
Low
$3.00
Median
$4.00
Data updated apr 24, 2026 10:30am
· Source: financialmodelingprep.com